IBA PROTON THERAPY, INC.

IBA Proton Therapy, Inc. is a high-technology healthcare company specializing in proton beam therapy systems for cancer treatment. Part of Ion Beam Applications (IBA), the company has supported the treatment of more than 140,000 cancer patients globally using its proton therapy equipment over the past 50 years. IBA's flagship product, the Proteus® system, is a versatile, image-guided, intensity-modulated proton therapy platform designed for oncology centers worldwide. The Proteus system delivers precise, conformal radiation to tumors while minimizing dose to surrounding healthy tissues, enabling treatment of a broader range of tumor types with reduced long-term side effects. The company is advancing next-generation technologies including DynamicARC® (a rotating gantry proton arc therapy system under development), ConformalFLASH® (ultra-high-dose-rate proton therapy), and Motion Management systems for treating mobile tumors with confidence. IBA operates or supports over 60 proton therapy centers globally and serves leading academic medical centers and cancer institutes. The company maintains strong relationships with radiation oncologists, medical physicists, and clinical researchers through its professional community. IBA's broader parent organization manufactures particle accelerators, dosimetry solutions, and radiopharmaceutical equipment in addition to proton therapy systems. Products are marketed toward comprehensive cancer centers, academic medical centers, and specialized proton therapy facilities globally.